Skip to main content
Erschienen in: Osteoporosis International 6/2009

01.06.2009 | Bone Quality Seminars: Ultrastructure

Effects of bone anabolic agents on bone ultrastructure

verfasst von: B. Cortet

Erschienen in: Osteoporosis International | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Excerpt

Currently, several effective anti-osteoporotic drugs are available, and their mechanisms of action are well known, albeit widely varying depending on the nature of the drugs involved. This paper addresses the following questions: Firstly, to what extent do these molecules and their mechanisms of action account for their antifracture efficacy? Secondly, it is known that changes in the values of intermediate parameters (BMD, bone remodelling markers) during treatment only partially account for the antifracture efficacy of these drugs. …
Literatur
1.
Zurück zum Zitat Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Minere Res 22:1173–1180CrossRef Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Minere Res 22:1173–1180CrossRef
2.
Zurück zum Zitat Paschalis EP, Glass EV, Donley DW, Eriksen EF (2005) Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 90:4644–4649PubMedCrossRef Paschalis EP, Glass EV, Donley DW, Eriksen EF (2005) Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 90:4644–4649PubMedCrossRef
3.
Zurück zum Zitat Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150–1156PubMedCrossRef Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150–1156PubMedCrossRef
4.
Zurück zum Zitat Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D. Effects of parathyroid hormone and alendronate on type 1 collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Mineral Res 2008 [Epubahead of print] Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D. Effects of parathyroid hormone and alendronate on type 1 collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Mineral Res 2008 [Epubahead of print]
5.
Zurück zum Zitat Boivin G, Deloffre P, Perrat B, Panczer B, Boudeulle M, Mauras Y et al (1996) Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 11:1302–1311PubMedCrossRef Boivin G, Deloffre P, Perrat B, Panczer B, Boudeulle M, Mauras Y et al (1996) Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 11:1302–1311PubMedCrossRef
6.
Zurück zum Zitat Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ (2005) Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 20:1569–1578PubMedCrossRef Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ (2005) Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 20:1569–1578PubMedCrossRef
7.
Zurück zum Zitat Amman P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419–1425CrossRef Amman P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419–1425CrossRef
8.
Zurück zum Zitat Boivin G (2007) The hydroxyapatite crystal: a closer look. Medicographia 29:126–132 Boivin G (2007) The hydroxyapatite crystal: a closer look. Medicographia 29:126–132
Metadaten
Titel
Effects of bone anabolic agents on bone ultrastructure
verfasst von
B. Cortet
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 6/2009
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-0862-9

Weitere Artikel der Ausgabe 6/2009

Osteoporosis International 6/2009 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.